QUOTED. 18 November 2019. Raymond Cohen.
Medtech giant Medtronic filed a patent infringement suit against Axonics, alleging Axonics' sacral neuromodulation technology infringes four of Medtronic's patents for implantable electrical stimulation lead fixation methods and transcutaneous inductive charging for implantable medical devices. See what Axonics CEO, Raymond Cohen, said about it here.
“We believe [Medtronic’s] claims are without merit and an attempt to suppress competition by confusing physician implanters with scare tactics." – Raymond Cohen, CEO, Axonics
Click here for a free trial of Medtech Insight